Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitReceivables - NetReceivables - OtherShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Medicure (MCUJF) Shares Issued (2016 - 2018)

Medicure has reported Shares Issued over the past 8 years, most recently at $31062.4 for Q4 2018.

  • For Q4 2018, Shares Issued changed N/A year-over-year to $31062.4; the TTM value through Dec 2019 reached $81550.5, down 71.19%, while the annual FY2023 figure was $41505.3, N/A changed from the prior year.
  • Shares Issued for Q4 2018 was $31062.4 at Medicure, down from $50488.1 in the prior quarter.
  • Over five years, Shares Issued peaked at $2.7 million in Q4 2015 and troughed at $1818.3 in Q2 2014.
  • A 5-year average of $327093.8 and a median of $90467.6 in 2016 define the central range for Shares Issued.
  • On a YoY basis, Shares Issued climbed as much as 5053.64% in 2016 and fell as far as 99.18% in 2016.
  • Year by year, Shares Issued stood at $1847.8 in 2014, then soared by 145862.59% to $2.7 million in 2015, then crashed by 99.18% to $22003.5 in 2016, then soared by 884.74% to $216678.4 in 2017, then tumbled by 85.66% to $31062.4 in 2018.
  • Business Quant data shows Shares Issued for MCUJF at $31062.4 in Q4 2018, $50488.1 in Q3 2018, and $48059.9 in Q2 2018.